References
- Body G P, Buckley M, Sathe Y S. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64: 328–340
- Souza L M, Boone T C, Gabrilove J. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
- Kitagawa S, Yuo A, Souza L M. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun. 1987; 144: 1143–1146
- Ohsaka A, Kitagawa S, Sakamoto S. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989; 74: 2743–2748
- Bronchud M H, Scarffe J H, Thatcher N. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809–813
- Morstyn G, Campbell L, Souza L M. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; i: 667–672
- Gabrilove J L, Jakubowski A, Scher H. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbility due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med. 1988; 318: 1414–1422
- Gabrilove J L, Jakubowski A, Fain K. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest. 1988; 82: 1454–1461
- Layton J E, Hockman H, Sheridan W P. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 1989; 74: 1303–1307
- Duhrsen U, Villeval J-L, Boyd J. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
- Sheridan W P, Morstyn G, Wolf M. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; ii: 891–895
- Morstyn G, Lieschke G J, Sheridan W. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Sent Hematol. 1989; 26: 9–13
- Morstyn G, Campbell L, Lieschke G. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol. 1989; 7: 1554–1562
- Neidhart J, Maugalik A, Kohler W. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J Clin Oncol. 1989; 7: 1685–1692
- Lindemann A, Herrmann F, Oster W. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989; 74: 2644–2651
- Lothrop C D, Waren D J, Souza L M. Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 1988; 72: 1324–1328
- Shuening F G, Storb R, Goehle S. Effects of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1989; 74: 1308–1313
- Azuma J, Tsuji S, Park S E. Phase I study of KRN 8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in consecutive subcutaneous administration. Clin Pharmacol. 1989; 5: 2253–2269, in Japanese
- Ogawa M, Masaoka T, Takaku F. Phase II study of KRN 8601 in patients with neutropenia induced by chemotherapy for malignant lymphoma. Clin Pharmacol. 1990; 6: 23–40, in Japanese
- Azuma J, Hamaguchi T, Seung-Eun P. Phase I study of KRN 8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in single intravenous infusion. Clin Pharmacol. 1989; 5: 1579–1603, in Japanese
- Blazar B R, Kersey J H, McGlave P B. In vivo administration of recombinant human granulocyte/ macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts. Blood 1989; 73: 849–857
- Guinan E C, Sieff C A, Oette D H. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 1990; 76: 1077–1082